Navigation Links
ERT Officials Ring the NASDAQ Closing Bell
Date:6/18/2009

PHILADELPHIA, June 18 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES), a leading provider of centralized ECG and eClinical technology, ePRO, and other services to the biopharmaceutical, medical device, and related industries, closed the stock market on 18 June by ringing the famous NASDAQ bell. Joel Morganroth, Chairman of the Board and Chief Scientific Officer, and Michael McKelvey, CEO, at ERT rang the NASDAQ MarketSite(R) closing bell in New York's Times Square.

Michael McKelvey took the opportunity to publicly thank all ERT employees, customers, and shareholders for their continuing support. Guests at the event included Board members and the senior management team - who joined Joel Morganroth and Michael McKelvey on stage for the ringing of the official closing bell.

Michael McKelvey said, "We are extremely honored, proud, and excited to have been invited by the NASDAQ Stock Exchange to participate in the closing bell ceremony. Ringing the closing bell has given us a unique opportunity to publicly thank our employees, customers, and shareholders for helping us get ERT to where it is today. It was also an excellent opportunity to further reinforce our presence within the NASDAQ community."

The highly celebrated event was beamed across the city streets courtesy of the landmark MarketSite Tower, while millions of viewers worldwide watched on the NASDAQ Webcam and participating television networks. The company's ticker symbol was displayed on the MarketSite Tower.

ERT is a leading provider of technology and services to the biopharmaceutical and medical device industries around the world. ERT products and services are all enabled by the Company's innovative technology platform - EXPERT(TM). EXPERT(TM) is a robust, secure, and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management, and information exchange. For further information on ERT and its technology and services please email info@ert.com, call +1 215 972 0420 or visit www.ert.com.

ERT will also be showcasing its portfolio of products and services on booth # 507 at the 45th Annual DIA Meeting, 21-25 June 2009 in San Diego, California, USA.

About ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) (www.ert.com) is a provider of technology and services to the global biopharmaceutical and medical device industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to, 2009 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
3. Easter Seals Awards State and Municipal Public Officials With 2007 Outstanding Advocate Awards
4. Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA
5. Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Legislators, Health Officials, Breast Cancer Survivors and Activists Call for Action on Breast Cancer
6. CDC Reports that Adult Smoking Declines Have Stalled; Elected Officials Should Step up Fight Against Tobacco
7. Central Mississippi Steel Magnolias Affiliate of Susan G. Komen for the Cure, Elected Officials, Health Leaders and Breast Cancer Survivors Call for Action to Reduce States High Breast Cancer Mortality Rate
8. State Health Officials Seek Quitters as Part of Great American Smokeout
9. Komen for the Cure Central New Mexico Affiliate, Lt. Gov. Diane Denish, Sen. Dede Feldman, Breast Cancer Survivors Call on Elected Officials to Close the Gap in Access to Breast Health Services
10. Marin County Scandal and Elder Abuse Horror: Lawsuits Link Death Nurse, Bay Area lawyers, Doctor and Blind Eye by Local, State, and National Public Officials
11. California Affiliates of Susan G. Komen for the Cure Convene Celebrities, Breast Cancer Survivors and Activists to Challenge Elected Officials to Strengthen Breast Cancer Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: